Eastern Maine Medical Center, Bangor, ME
Anannya Patwari, Vineel Bhatlapenumarthi, Courtney Brann, Jackson Waldrip, Victoria Caruso, Abigail Hatch, Adam Curtis, Catherine Chodkiewicz
Background: Reducing ED visits in patients with cancer is cost saving and is particularly relevant during the COVID pandemic. We aim to identify patterns of ED visits among various cancer patients and reduce preventable ED visits and hospital admissions. Methods: We analyzed the number of ED visits and hospital admissions that occurred in patients with breast, lung, and Gastrointestinal (GI) cancers between July12019 and October31 2020 including demographics, stage, treatment type preceding the month of ED visit, reason, time of the day, day of the week the visit occurred. Results: 308 patients had 519 ED visits, 111 breast cancer patients had 184, 102 lung cancer patients had 186 and 95 GI cancer patients had 149 ED visits. 38% had > 1 visit. 51%, (37% breast, 60% Lung and 58 % GI cancer) had stage 4 disease at the time of visit. There were no visits in the month of May 2020. 275 (53%) visits required hospital admissions, 60% of ED visits in lung cancer, 54% in GI and 46 % in breast cancer patients required hospitalization. Most common reason for ED visits in breast cancer patients was fall/injury (20%), with median age of 71 years, none were cancer/ chemotherapy induced. Among lung and GI cancer patients respiratory (24%) and GI related (24%) symptoms were the most common reasons respectively, majority were cancer/chemotherapy related. Most common symptoms requiring hospital admissions were respiratory 21%, GI 18%, cardiac 12%. 11% and 9% of ED visits were due to fall/injury and cancer related pain, of these 3.6% and 9% resulted in hospital admissions respectively. Lung and GI cancer patients were more likely to be referred to the ED from the oncologist office (23%) than breast cancer patients (11%). Conclusions: Reasons for ED visits vary by tumor types and some may be preventable. Fall/injury in breast cancer patients and cancer related pain in lung and GI cancer patients were frequent reasons for preventable ED visits. In lung and GI cancer patients, cancer/chemotherapy related respiratory, GI symptoms are felt to be less avoidable since they may be related to disease progression or presenting symptoms. We have initiated several strategies such as ‘’systematic physical therapy assessment’’ of our breast cancer patients over age 70 to reduce ED visits due to fall/injury. We are developing strategies to involve palliative care early to reduce the number of ED visits related to cancer related pain We now have “call us first campaign” to assess and intervene before going to ED since most visits occurred during working hours.
Type of cancer | Specific Symptom | Total ER Visits | Hospital Admissions | Chemo Induced | Cancer Induced | Not Cancer/chemo Related |
---|---|---|---|---|---|---|
Breast cancer | Fall Injury | 37 | 6 | 0 | 0 | 37 |
GI | 28 | 15 | 8 | 6 | 14 | |
Cardiac | 20 | 15 | 0 | 2 | 18 | |
Lung cancer | Respiratory | 45 | 38 | 1 | 33 | 11 |
GI | 23 | 11 | 9 | 8 | 6 | |
Cancer related pain | 21 | 13 | 0 | 21 | 0 | |
GI cancer | GI | 36 | 23 | 3 | 31 | 2 |
Respiratory | 17 | 10 | 1 | 9 | 7 | |
Cancer related pain | 17 | 9 | 0 | 17 | 0 |
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Abstract Disclosures
2021 ASCO Annual Meeting
First Author: Anannya Patwari
2023 ASCO Quality Care Symposium
First Author: Hetal Mistry
2023 ASCO Annual Meeting
First Author: Jaswinder Singh
2024 ASCO Annual Meeting
First Author: S.P. Somashekhar